Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2011
12/01/2011US20110294165 Variant humicola grisea cbh1.1
12/01/2011US20110294164 Variant humicola grisea cbh1.1
12/01/2011US20110294149 Alzheimer's Disease Secretase, APP Substrates Therefor, and Uses Therefor
12/01/2011US20110294147 Serological screening for hhv-8 infection using antigen mixtures
12/01/2011US20110294145 Reagents and methods for detecting a polymorphic protein
12/01/2011US20110294137 Sensor
12/01/2011US20110294128 Concentration and Enrichment of Microbial Cells and Microbial Nucleic Acids from Bodily Fluids
12/01/2011US20110294127 Elite event a2704-12 and methods and kits for identifying such event in biological samples
12/01/2011US20110294124 Method for the synthesis of phosphorus atom modified nucleic acids
12/01/2011US20110294123 Methods for diagnosing or treating prostate cancer
12/01/2011US20110294120 Probes for Detection of SULT1A1 Gene, Reagent Containing the Same, and the Uses Thereof
12/01/2011US20110294119 Novel methods of differentiating yeast strains and/or determining genetic stability of yeast strains, and uses thereof
12/01/2011US20110294118 Water soluble fluorescent compounds
12/01/2011US20110294114 Optimization of determinants for successful genetic correction of diseases, mediated by hematopoietic stem cells
12/01/2011US20110293815 Corn plants and seed enhanced for asparagine and protein
12/01/2011US20110293708 Process for preparing purified nucleic acid and the use thereof
12/01/2011US20110293703 Aminoalcohol lipidoids and uses thereof
12/01/2011US20110293702 Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS
12/01/2011US20110293698 Reagents and Methods for Treating Cancer
12/01/2011US20110293664 Chlamydia antigens and uses thereof
12/01/2011US20110293656 Recombinant mva capable of expressing structural hcv antigens
12/01/2011US20110293652 Chimeric ospa genes, proteins, and methods of use thereof
12/01/2011US20110293650 Influenza virus-like particles (vlps) comprising hemagglutinin
12/01/2011US20110293645 Wdrpuh epitope peptides and vaccines containing the same
12/01/2011US20110293644 Compositions and methods for treatment of celiac disease
12/01/2011US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011US20110293621 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
12/01/2011US20110293620 Monoclonal Antibodies For Use In Diagnosis and Therapy of Cancers and Autoimmune Disease
12/01/2011US20110293619 CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
12/01/2011US20110293618 Anti-human clcp1 antibody and use thereof
12/01/2011US20110293617 Anti-p-selectin antibodies and methods of their use and identification
12/01/2011US20110293613 Bispecific antibodies
12/01/2011US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
12/01/2011US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011US20110293608 Annexin a2 as immunological target
12/01/2011US20110293599 Method for modulating muscle differentiation or regeneration
12/01/2011US20110293597 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
12/01/2011US20110293587 Glucagon analogues
12/01/2011US20110293586 Glucagon analogues
12/01/2011US20110293585 Compositions and methods for treatment of lysosomal storage disorders
12/01/2011US20110293579 Bi-specific fusion proteins
12/01/2011US20110293566 Diffocin and methods of use thereof
12/01/2011US20110293565 Novel synthetic agonists of tlr9
12/01/2011US20110293557 Conjugates for the administration of biologically active compounds
12/01/2011CA2799501A1 Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
11/2011
11/30/2011EP2390259A2 Amplification and detection reagents for HIV-1
11/30/2011EP2390258A1 High fidelity polymerases and uses thereof
11/30/2011EP2390256A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
11/30/2011EP2389455A1 Methods and compositions for identifying a fetal cell
11/30/2011EP2389454A1 Method for enrichment of selected rna molecules
11/30/2011EP1633372B1 Vaccines, immunotherapeutics and methods for using the same
11/30/2011EP1075544B1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
11/30/2011CN1656222B 反义iap核碱基寡聚物及其应用 Iap nucleobase antisense oligomer and its application
11/30/2011CN102264914A 用于修饰核酸的转座子末端组合物和方法 Transposon terminus modified nucleic acid compositions and methods for
11/30/2011CN102264899A 弯曲的玻璃表面上的核酸提取 Extraction of nucleic acids on the curved surface of the glass
11/30/2011CN102264374A 5′和2′双取代的核苷和由其制备的低聚化合物 5 'and 2' substituted nucleoside and double oligomeric compounds prepared therefrom
11/29/2011US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011US8067672 Flower tissue-specific promoter and uses thereof
11/29/2011US8067670 Plants that produce amylopectin starch with novel properties
11/29/2011US8067581 Biomolecules having multiple attachment moieties for binding to a substrate surface
11/29/2011US8067580 Isolation of DNA, RNA and protein from a single sample
11/29/2011US8067579 Nucleic acid extraction method
11/29/2011US8067578 Substrate preparation process
11/29/2011US8067577 Methods and compositions for the treatment of intestinal conditions
11/29/2011US8067576 siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)
11/29/2011US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011US8067574 Nucleic acid agents for downregulating H19, and methods of using same
11/29/2011US8067573 Nucleic acid agents for downregulating H19 and methods of using same
11/29/2011US8067572 Hybrid interfering RNA
11/29/2011US8067571 Conjugating an arginine-rich carrier to a 3' or 5' end; phosphorodiamidate linkages
11/29/2011US8067570 Therapeutic uses of inhibitors of RTP801
11/29/2011US8067569 Splice-region antisense composition and method
11/29/2011US8067568 Method for diagnosing spinal muscular atrophy
11/29/2011US8067567 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
11/29/2011US8067564 Methods of obtaining a specific binding member that binds eotaxin
11/29/2011US8067563 Tumor suppressor gene, p471NG3
11/29/2011US8067562 Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
11/29/2011US8067561 Isolated DNA encoding recombinant glucose isomerase
11/29/2011US8067560 SRSV detection kit
11/29/2011US8067559 Yeast-based vaccines as immunotherapy
11/29/2011US8067558 Constitutively active fragments of eukaryotic heat shock RNA
11/29/2011US8067557 OCL-2A3 compositions and uses thereof
11/29/2011US8067556 Multi-site mutagenesis
11/29/2011US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium
11/29/2011US8067529 Immunogenic T-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
11/29/2011US8067389 Silencing of TGFβ type II receptor expression by siRNA
11/29/2011US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011US8067386 Modulation of eIF4E-BP2 expression
11/29/2011US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011US8067239 Reagents for recombinogenic engineering and use thereof
11/29/2011US8067236 Optimized human T1R3 nucleic acid molecule
11/29/2011US8067235 Optimized human T1R2 nucleic acid molecule
11/29/2011US8067231 Clostridial toxin activity assays
11/29/2011US8067227 Viral vectors and the use of the same for gene therapy
11/29/2011US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
11/29/2011US8067211 Method for production of L-glutamine
11/29/2011US8067210 Method of producing lysine by culturing a host cell expressing a polynucleotide encoding a feedback resistant aspartokinase from corynebacterium
11/29/2011US8067207 Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
11/29/2011US8067197 Soluble recombinant αvβ3 adhesion receptor